Hyundai Pharmaceutical Co., Ltd. (004310) Revenue

― Followers

Hyundai Pharmaceutical Co., Ltd. Revenue

Hyundai Pharmaceutical Co., Ltd. had a revenue of 55.59B in the quarter ending May 31, 2026, with 19.66%. This bring the company's revenue in the last twelve months to 202.33B, Decreased 3.67%. In the fiscal year ending Nov 30, 2025, Hyundai Pharmaceutical Co., Ltd. had annual revenue of 191.79B with 9.14% growth.

Revenue (ttm)

202.33B

Revenue Growth

12.04%

P/S Ratio

1.35

Revenue/Employee

₩480,689,221

Employees

399

Market Cap

₩259.70B

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Nov 30, 2025	191.79B	16.06B	+9.14%
Nov 30, 2024	175.74B	-5.03B	-2.78%
Nov 30, 2023	180.76B	18.07B	+11.11%
Nov 30, 2022	162.69B	22.89B	+16.37%
Nov 30, 2021	139.80B	6.84B	+5.14%
Nov 30, 2020	132.97B	-1.68B	-1.25%
Nov 30, 2019	134.65B	3.86B	+2.95%
Nov 30, 2018	130.79B	310.48M	+0.24%
Nov 30, 2017	130.48B	―	―